Pfizer Inc.
PFE
$26.57
-$0.01-0.04%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 62.58B | 62.79B | 63.83B | 62.46B | 63.63B |
| Total Other Revenue | -- | -1.00M | 0.00 | 0.00 | 0.00 |
| Total Revenue | 62.58B | 62.79B | 63.83B | 62.46B | 63.63B |
| Cost of Revenue | 15.14B | 16.59B | 17.48B | 16.75B | 17.19B |
| Gross Profit | 47.44B | 46.20B | 46.35B | 45.72B | 46.44B |
| SG&A Expenses | 13.02B | 14.03B | 14.06B | 14.33B | 14.77B |
| Depreciation & Amortization | 4.88B | 5.00B | 5.09B | 5.19B | 5.29B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.47B | 45.84B | 46.92B | 46.78B | 48.06B |
| Operating Income | 19.11B | 16.95B | 16.91B | 15.68B | 15.56B |
| Income Before Tax | 7.52B | 9.15B | 10.53B | 7.39B | 8.02B |
| Income Tax Expenses | -266.00M | -685.00M | -235.00M | -510.00M | -28.00M |
| Earnings from Continuing Operations | 7.79K | 9.84K | 10.77K | 7.90K | 8.05K |
| Earnings from Discontinued Operations | 25.00M | 32.00M | 24.00M | 16.00M | 11.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -41.00M | -41.00M | -40.00M | -29.00M | -31.00M |
| Net Income | 7.77B | 9.83B | 10.75B | 7.88B | 8.03B |
| EBIT | 19.11B | 16.95B | 16.91B | 15.68B | 15.56B |
| EBITDA | 25.66B | 23.63B | 23.68B | 22.56B | 22.56B |
| EPS Basic | 1.37 | 1.73 | 1.89 | 1.39 | 1.42 |
| Normalized Basic EPS | 2.07 | 1.68 | 1.63 | 1.49 | 1.45 |
| EPS Diluted | 1.36 | 1.72 | 1.89 | 1.39 | 1.42 |
| Normalized Diluted EPS | 2.07 | 1.67 | 1.62 | 1.49 | 1.44 |
| Average Basic Shares Outstanding | 22.73B | 22.71B | 22.69B | 22.68B | 22.66B |
| Average Diluted Shares Outstanding | 22.82B | 22.83B | 22.82B | 22.81B | 22.80B |
| Dividend Per Share | 2.15 | 2.13 | 2.12 | 2.11 | 2.10 |
| Payout Ratio | 94.29% | 73.88% | 66.94% | 121.49% | 118.44% |